Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Leukemia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 72 articles:
HTML format



Single Articles


    January 2022
  1. COLUNGA-LOZANO LE, Kenji Nampo F, Agarwal A, Desai P, et al
    Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263240.
    PubMed     Abstract available


  2. HARVEY MJ, Zhong Y, Morris E, Beverage JN, et al
    Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma.
    PLoS One. 2022;17:e0261336.
    PubMed     Abstract available


  3. HUANG HH, Chen CM, Wang CY, Hsu WW, et al
    The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan.
    PLoS One. 2022;17:e0261871.
    PubMed     Abstract available


  4. HOWELL DA, McCaughan D, Smith AG, Patmore R, et al
    Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
    PLoS One. 2022;17:e0263672.
    PubMed     Abstract available


  5. ZAREI GHOBADI M, Emamzadeh R
    Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
    PLoS One. 2022;17:e0262739.
    PubMed     Abstract available


  6. ASHOTI A, Limone F, van Kranenburg M, Alemany A, et al
    Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen.
    PLoS One. 2022;17:e0263262.
    PubMed     Abstract available


  7. NORTHGRAVES M, Allsup D, Cohen J, Huang C, et al
    A prospective registry-based cohort study of the diagnosis and management of acute leukaemia in pregnancy: Study protocol.
    PLoS One. 2022;17:e0263195.
    PubMed     Abstract available


  8. SAJIKI Y, Konnai S, Okagawa T, Maekawa N, et al
    Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.
    PLoS One. 2022;17:e0263660.
    PubMed     Abstract available


  9. SHELTON DN, Bhagavatula P, Sepulveda N, Beppu L, et al
    Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia.
    PLoS One. 2022;17:e0265278.
    PubMed     Abstract available


  10. KUBO H, Imataki O, Kubo YH, Uemura M, et al
    c-D-index at day 11 can predict febrile neutropenia during chemotherapy in acute myeloid leukemia.
    PLoS One. 2022;17:e0263623.
    PubMed     Abstract available


  11. VAZQUEZ-CORNEJO E, Morales-Rios O, Hernandez-Pliego G, Cicero-Oneto C, et al
    Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.
    PLoS One. 2022;17:e0265450.
    PubMed     Abstract available


  12. CESARO E, Falanga AP, Catapano R, Greco F, et al
    Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0266090.
    PubMed     Abstract available


  13. SZCZESNIAK PP, Heidelberger JB, Serve H, Beli P, et al
    VCP inhibition induces an unfolded protein response and apoptosis in human acute myeloid leukemia cells.
    PLoS One. 2022;17:e0266478.
    PubMed     Abstract available


  14. PARE A, Ellis A, Juette T
    Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008-2019).
    PLoS One. 2022;17:e0266621.
    PubMed     Abstract available


  15. PEARSON S, Whetton AD, Pierce A
    Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells.
    PLoS One. 2022;17:e0266298.
    PubMed     Abstract available


  16. MOPIN A, Lepretre F, Sebda S, Villenet C, et al
    Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
    PLoS One. 2022;17:e0267508.
    PubMed     Abstract available


  17. MATOU-NASRI S, Najdi M, AlSaud NA, Alhaidan Y, et al
    Blockade of p38 MAPK overcomes AML stem cell line KG1a resistance to 5-Fluorouridine and the impact on miRNA profiling.
    PLoS One. 2022;17:e0267855.
    PubMed     Abstract available


  18. YAMAMOTO N, Kikuchi J, Furukawa Y, Shibayama N, et al
    Fast in-vitro screening of FLT3-ITD inhibitors using silkworm-baculovirus protein expression system.
    PLoS One. 2022;17:e0261699.
    PubMed     Abstract available


  19. HIRANO S, Udagawa O
    Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    PLoS One. 2022;17:e0268835.
    PubMed     Abstract available


  20. HERNANDEZ VA, Carvajal-Moreno J, Wang X, Pietrzak M, et al
    Use of CRISPR/Cas9 with homology-directed repair to silence the human topoisomerase IIalpha intron-19 5' splice site: Generation of etoposide resistance in human leukemia K562 cells.
    PLoS One. 2022;17:e0265794.
    PubMed     Abstract available


  21. SIAMAKPOUR-REIHANI S, Cao F, Lyu J, Ren Y, et al
    Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
    PLoS One. 2022;17:e0268963.
    PubMed     Abstract available


  22. GARNIASIH D, Susanah S, Sribudiani Y, Hilmanto D, et al
    The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269706.
    PubMed     Abstract available


  23. VIJAYVARGIYA P, Feri A, Mairey M, Rouillon C, et al
    Metagenomic shotgun sequencing of blood to identify bacteria and viruses in leukemic febrile neutropenia.
    PLoS One. 2022;17:e0269405.
    PubMed     Abstract available


  24. LIISBORG C, Skov V, Kjaer L, Hasselbalch HC, et al
    Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers.
    PLoS One. 2022;17:e0269960.
    PubMed     Abstract available


  25. BORODIN AM, Emanuilova ZV, Smolov SV, Ogneva OA, et al
    Eradication of avian leukosis virus subgroups J and K in broiler cross chickens by selection against infected birds using multilocus PCR.
    PLoS One. 2022;17:e0269525.
    PubMed     Abstract available


  26. FODIL S, Chevret S, Rouzaud C, Valade S, et al
    Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications.
    PLoS One. 2022;17:e0270744.
    PubMed     Abstract available


  27. FLO M, Carrion F, Olivero-Deibe N, Bianchi S, et al
    Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.
    PLoS One. 2022;17:e0271671.
    PubMed     Abstract available


  28. BULTUM LE, Tolossa GB, Lee D
    Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    PLoS One. 2022;17:e0270050.
    PubMed     Abstract available


  29. DONG K, Heidari M, Mays J, Chang S, et al
    A comprehensive analysis of avian lymphoid leukosis-like lymphoma transcriptomes including identification of LncRNAs and the expression profiles.
    PLoS One. 2022;17:e0272557.
    PubMed     Abstract available


  30. YOO J, Cho HS, Yoon JH, Cho BS, et al
    Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study.
    PLoS One. 2022;17:e0273827.
    PubMed     Abstract available


  31. MIKHAYLENKO N, Wahnschaffe L, Herling M, Roeder I, et al
    Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.
    PLoS One. 2022;17:e0274463.
    PubMed     Abstract available


  32. MOSQUERA ORGUEIRA A, Peleteiro Raindo A, Cid Lopez M, Antelo Rodriguez B, et al
    Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.
    PLoS One. 2022;17:e0274984.
    PubMed     Abstract available


  33. KONGTA R, Panyasit N, Jansaento W, Duangmano S, et al
    Development of E-ice-COLD-PCR assay combined with HRM analysis for Nucleophosmin1 gene mutation detection in acute myelogenous leukemia.
    PLoS One. 2022;17:e0274034.
    PubMed     Abstract available


  34. DEERING KL, Sundaram M, Harshaw Q, Trudeau J, et al
    Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study.
    PLoS One. 2022;17:e0270291.
    PubMed     Abstract available


  35. MALETZKE S, Salimi A, Vieri M, Schroeder KM, et al
    Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia.
    PLoS One. 2022;17:e0268352.
    PubMed     Abstract available


  36. SZELEST M, Masternak M, Zajac M, Chojnacki M, et al
    The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0276674.
    PubMed     Abstract available


  37. CHEN Y, Wu T, Yang C, Lu M, et al
    A pyridinesulfonamide derivative FD268 suppresses cell proliferation and induces apoptosis via inhibiting PI3K pathway in acute myeloid leukemia.
    PLoS One. 2022;17:e0277893.
    PubMed     Abstract available


    January 2021
  38. ELENS I, Deprez S, Billiet T, Sleurs C, et al
    Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors.
    PLoS One. 2021;16:e0250228.
    PubMed     Abstract available


  39. YOO KH, Kim HJ, Min YH, Hong DS, et al
    Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry.
    PLoS One. 2021;16:e0251011.
    PubMed     Abstract available


  40. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed     Abstract available


  41. MOHSENI M, Kucharski C, K C RB, Nasrullah M, et al
    Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    PLoS One. 2021;16:e0251719.
    PubMed     Abstract available


  42. KOVY P, Orfi Z, Bors A, Kozma A, et al
    Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    PLoS One. 2021;16:e0253386.
    PubMed     Abstract available


  43. KIM SK, Goughnour PC, Lee EJ, Kim MH, et al
    Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.
    PLoS One. 2021;16:e0246106.
    PubMed     Abstract available


  44. PONVILAWAN B, Kungwankiattichai S, Charoenngam N, Owattanapanich W, et al
    Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253896.
    PubMed     Abstract available


  45. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed     Abstract available


  46. KARAMI K, Akbari M, Moradi MT, Soleymani B, et al
    Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
    PLoS One. 2021;16:e0254976.
    PubMed     Abstract available


  47. MOUSTAFA R, Albouni T, Aziz G
    The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    PLoS One. 2021;16:e0253842.
    PubMed     Abstract available


  48. FAUZI YR, Nakahata S, Chilmi S, Ichikawa T, et al
    Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-kappaB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    PLoS One. 2021;16:e0256320.
    PubMed     Abstract available


  49. ZHANG W, Jang E
    Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
    PLoS One. 2021;16:e0256801.
    PubMed     Abstract available


  50. LONCAREVIC IF, Toepfer S, Hubold S, Klingner S, et al
    Ultra-precise quantification of mRNA targets across a broad dynamic range with nanoreactor beads.
    PLoS One. 2021;16:e0242529.
    PubMed     Abstract available


  51. VON BEEK C, Alriksson L, Palle J, Gustafson AM, et al
    Dynamin inhibition causes context-dependent cell death of leukemia and lymphoma cells.
    PLoS One. 2021;16:e0256708.
    PubMed     Abstract available


  52. GONZALEZ-RINCON J, Garcia-Vela JA, Gomez S, Fernandez-Cuevas B, et al
    Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
    PLoS One. 2021;16:e0257353.
    PubMed     Abstract available


  53. OCHIAI C, Miyauchi S, Kudo Y, Naruke Y, et al
    Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing.
    PLoS One. 2021;16:e0256588.
    PubMed     Abstract available


  54. ROSENTHAL SH, Gerasimova A, Ma C, Li HR, et al
    Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
    PLoS One. 2021;16:e0243683.
    PubMed     Abstract available


  55. MATSUO S, Nishinaka-Arai Y, Kazuki Y, Oshimura M, et al
    Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    PLoS One. 2021;16:e0247595.
    PubMed     Abstract available


  56. OLAYA-GALAN NN, Salas-Cardenas SP, Rodriguez-Sarmiento JL, Ibanez-Pinilla M, et al
    Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study.
    PLoS One. 2021;16:e0257492.
    PubMed     Abstract available


  57. LUONG A, Cerignoli F, Abassi Y, Heisterkamp N, et al
    Analysis of acute lymphoblastic leukemia drug sensitivity by changes in impedance via stromal cell adherence.
    PLoS One. 2021;16:e0258140.
    PubMed     Abstract available


  58. BAO F, Zhang L, Pei X, Lian C, et al
    MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia.
    PLoS One. 2021;16:e0256995.
    PubMed     Abstract available


  59. MOSQUERA ORGUEIRA A, Ferreiro Ferro R, Diaz Arias JA, Aliste Santos C, et al
    Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    PLoS One. 2021;16:e0248886.
    PubMed     Abstract available


  60. PARKER C, Zomer E, Liew D, Ayton D, et al
    Characterising experiences with acute myeloid leukaemia using an Instagram content analysis.
    PLoS One. 2021;16:e0250641.
    PubMed     Abstract available


  61. ONO R, Masuya M, Inoue N, Shinmei M, et al
    Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    PLoS One. 2021;16:e0248425.
    PubMed     Abstract available


  62. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available


  63. MAHESHWARI VK, Slader C, Dani N, Gkitzia C, et al
    Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China.
    PLoS One. 2021;16:e0259076.
    PubMed     Abstract available


  64. SEOMUN G, Lee J, Park J
    Exposure to extremely low-frequency magnetic fields and childhood cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251628.
    PubMed     Abstract available


  65. SADATO D, Hirama C, Kaiho-Soma A, Yamaguchi A, et al
    Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
    PLoS One. 2021;16:e0255257.
    PubMed     Abstract available


  66. NAGY-BALO Z, Kiss R, Demeter J, Bodor C, et al
    BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.
    PLoS One. 2021;16:e0254853.
    PubMed     Abstract available


  67. HOFFMANN H, Baldow C, Zerjatke T, Gottschalk A, et al
    How to predict relapse in leukemia using time series data: A comparative in silico study.
    PLoS One. 2021;16:e0256585.
    PubMed     Abstract available


  68. CARDOSO BORGES F, Ramos A, Lourenco A, Gomes da Silva M, et al
    Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
    PLoS One. 2021;16:e0258423.
    PubMed     Abstract available


  69. BOLOURI H, Ries R, Pardo L, Hylkema T, et al
    A B-cell developmental gene regulatory network is activated in infant AML.
    PLoS One. 2021;16:e0259197.
    PubMed     Abstract available


  70. WAN PUTEH SE, Aizuddin AN, Tumian NR, Sathar J, et al
    Health-related quality of life using EQ-5D among chronic myeloid leukaemia patients in health centres in Klang Valley, Malaysia.
    PLoS One. 2021;16:e0256804.
    PubMed     Abstract available


  71. CHOI KH, Song JH, Kwak YK, Lee JH, et al
    Analysis of PET parameters predicting response to radiotherapy for myeloid sarcoma.
    PLoS One. 2021;16:e0261550.
    PubMed     Abstract available


  72. RODRIGUEZ OL, Sharp AJ, Watson CT
    Limitations of lymphoblastoid cell lines for establishing genetic reference datasets in the immunoglobulin loci.
    PLoS One. 2021;16:e0261374.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: